More than 30 million US adults have hearing loss. This condition is underrecognized, and
hearing aids and other hearing enhancement technologies are underused. Hearing loss is …

According to a recent epidemiological survey, the incidence of sudden sensorineural
hearing loss (SSNHL) is increasing yearly. The cause of SSNHL is of great interest in …

Objective Sudden hearing loss is a frightening symptom that often prompts an urgent or
emergent visit to a health care provider. It is frequently but not universally accompanied by …

Objective Sudden hearing loss is a frightening symptom that often prompts an urgent or
emergent visit to a health care provider. It is frequently, but not universally, accompanied by …

Childhood, adolescent, and young adult (CAYA) cancer survivors treated with platinum-
based drugs, head or brain radiotherapy, or both have an increased risk of ototoxicity …

Objective: To provide an overview of biotechnology and pharmaceutical companies active in
the field of inner ear and central hearing disorders and their therapeutic approaches …

Objective: To confirm the efficacy and safety of AM-111 (brimapitide), a cell-penetrating c-
Jun N-terminal Kinase (JNK) inhibitor, in patients suffering from severe to profound acute …

5-HT3 receptor antagonists, first introduced to the market in the mid-1980s, are proven
efficient agents to counteract chemotherapy-induced emesis. Nonetheless, recent …

Background Hearing loss is one of the leading causes of disability worldwide. Patients with
hearing loss experience impaired quality of life, as well as emotional and financial …

Objective: Sudden sensorineural hearing loss (SSNHL) is a common acute disease with an
incidence of 0.5–2/10,000. This study aimed to determine whether the neutrophil-to …